Compare ATR & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATR | CHWY |
|---|---|---|
| Founded | 1992 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Catalog/Specialty Distribution |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.5B |
| IPO Year | 1995 | 2019 |
| Metric | ATR | CHWY |
|---|---|---|
| Price | $124.27 | $19.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 24 |
| Target Price | ★ $170.25 | $43.52 |
| AVG Volume (30 Days) | 439.7K | ★ 9.9M |
| Earning Date | 04-30-2026 | 06-10-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 6.51 | N/A |
| EPS | ★ 1.12 | 0.23 |
| Revenue | $3,777,181,000.00 | ★ $12,601,500,000.00 |
| Revenue This Year | $5.18 | $10.70 |
| Revenue Next Year | $4.98 | $7.84 |
| P/E Ratio | $107.69 | ★ $77.61 |
| Revenue Growth | 5.42 | ★ 6.24 |
| 52 Week Low | $103.23 | $17.40 |
| 52 Week High | $164.28 | $43.50 |
| Indicator | ATR | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 66.85 | 42.25 |
| Support Level | $117.57 | N/A |
| Resistance Level | $125.87 | $22.81 |
| Average True Range (ATR) | 3.27 | 1.02 |
| MACD | 1.18 | -0.02 |
| Stochastic Oscillator | 93.95 | 40.15 |
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Chewy is the largest e-commerce petcare retailer in the US, generating $12.6 billion in fiscal 2025 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, veterinary care, membership fees, sponsored ads, and hard goods like crates, leashes, and bowls.